戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 elop a spontaneous, chronic, and progressive uveoretinitis.
2 del of human uveitis-experimental autoimmune uveoretinitis.
3 ologic expression of experimental autoimmune uveoretinitis.
4 ferred naive CD4(+) T cells, and significant uveoretinitis.
5 e autoimmune disease experimental autoimmune uveoretinitis.
6  in the induction of experimental autoimmune uveoretinitis.
7 ouse eyes developing experimental autoimmune uveoretinitis.
8  phagocytes, leading to the amplification of uveoretinitis.
9 laboratory models of experimental autoimmune uveoretinitis.
10 n a primate model of experimental autoimmune uveoretinitis.
11 in S-antigen-induced experimental autoimmune uveoretinitis.
12 from donor rats with experimental autoimmune uveoretinitis.
13 therapeutic target in the treatment of human uveoretinitis.
14 s (EAU), a murine model for human autoimmune uveoretinitis.
15                                   Autoimmune uveoretinitis accounts for at least 10% of worldwide bli
16   B10.A mice develop experimental autoimmune uveoretinitis after active immunization with the interph
17 sis, we investigated experimental autoimmune uveoretinitis, an animal model for human uveitis.
18 opment in the thymus to their involvement in uveoretinitis and compared tolerogenic mechanisms induce
19 ent to the retina in experimental autoimmune uveoretinitis and promotes chronicity in the form of a p
20 pathologies, including diabetic retinopathy, uveoretinitis, and primary open-angle glaucoma.
21 genic HEL-specific TCR spontaneously develop uveoretinitis at post-partum day (P)20/21.
22 ithin the eye during experimental autoimmune uveoretinitis correlates with peroxynitrite formation in
23 r the development of experimental autoimmune uveoretinitis (EAU) affects macrophage function.
24 ng a murine model of experimental autoimmune uveoretinitis (EAU) and the recently identified microgli
25 enetic resistance to experimental autoimmune uveoretinitis (EAU) are connected to a predisposition to
26  (SOCS1-Tg), induced experimental autoimmune uveoretinitis (EAU) by active immunization with interpho
27 g the early phase of experimental autoimmune uveoretinitis (EAU) causes peroxidation of docosahexaeno
28 nt susceptibility to experimental autoimmune uveoretinitis (EAU) for tissue resident APC.
29  previous studies of experimental autoimmune uveoretinitis (EAU) have shown that nasal antigen admini
30                      Experimental autoimmune uveoretinitis (EAU) in mice is a model for human autoimm
31                      Experimental autoimmune uveoretinitis (EAU) in mice is an important model for el
32 ity vs resistance to experimental autoimmune uveoretinitis (EAU) in mice is associated with dominant
33 al antigen eliciting experimental autoimmune uveoretinitis (EAU) in mice.
34  the pathogenesis of experimental autoimmune uveoretinitis (EAU) in mice.
35 s (MSCs) ameliorated experimental autoimmune uveoretinitis (EAU) in rats.
36                      Experimental autoimmune uveoretinitis (EAU) is a cell-mediated model of retinal
37                      Experimental autoimmune uveoretinitis (EAU) is a mouse model of human autoimmune
38                      Experimental autoimmune uveoretinitis (EAU) is a T-cell-mediated disease induced
39 73-283 itself causes experimental autoimmune uveoretinitis (EAU) only at 200 nmol/rat, whereas peptid
40 -/-)) do not develop experimental autoimmune uveoretinitis (EAU) or experimental autoimmune encephalo
41                      Experimental autoimmune uveoretinitis (EAU) serves as a model for several immune
42 ions of these APC in experimental autoimmune uveoretinitis (EAU) were examined.
43 n the development of experimental autoimmune uveoretinitis (EAU), a cell-mediated, Th1-driven autoimm
44 n the development of experimental autoimmune uveoretinitis (EAU), a model for autoimmune uveitis in h
45 date our findings in experimental autoimmune uveoretinitis (EAU), a model of uveitis.
46 ependency is seen in experimental autoimmune uveoretinitis (EAU), a mouse model of endogenous human a
47                      Experimental autoimmune uveoretinitis (EAU), an animal model for human intraocul
48               During experimental autoimmune uveoretinitis (EAU), expression of both OX2 and OX2R was
49 c features of murine experimental autoimmune uveoretinitis (EAU), with the intent of generating a rap
50  mice recovered from experimental autoimmune uveoretinitis (EAU).
51 toantigen to develop experimental autoimmune uveoretinitis (EAU).
52 urse and severity of experimental autoimmune uveoretinitis (EAU).
53 model of spontaneous experimental autoimmune uveoretinitis (EAU).
54  autoimmune disease (experimental autoimmune uveoretinitis, EAU) and gave no evidence of Ag recogniti
55          In monkeys, experimental autoimmune uveoretinitis evolution was significantly inhibited by H
56           Voclosporin effectively suppressed uveoretinitis in an animal model that imitates the human
57 less than 10,000 kDa, is capable of inducing uveoretinitis in Lewis rats.
58 ith beta-gal induced experimental autoimmune uveoretinitis indistinguishable from that induced by kno
59 ific iTregs enhanced experimental autoimmune uveoretinitis induced by activated betagal-specific effe
60                      Experimental autoimmune uveoretinitis is a model for noninfectious posterior seg
61                                   Autoimmune uveoretinitis is a significant cause of visual loss, and
62               Murine experimental autoimmune uveoretinitis is induced by activation of retinal antige
63                       Although noninfectious uveoretinitis is mediated by CD4(+) T cells, in the pers
64 el of human uveitis, experimental autoimmune uveoretinitis permits assessment of immunotherapeutic ef
65 rate in WT mice with experimental autoimmune uveoretinitis showed a mixed population, comprising neut
66                2) In experimental autoimmune uveoretinitis, the inflammatory mediator expression patt
67 beta-gal transferred experimental autoimmune uveoretinitis to the transgenic mice with high level ret
68                      Experimental autoimmune uveoretinitis was dramatically reduced in G-CSF-deficien
69                      Experimental autoimmune uveoretinitis was induced in B10.A mice by immunization
70 17 helper T cells in experimental autoimmune uveoretinitis was reduced with G-CSF deficiency.
71            Moreover, experimental autoimmune uveoretinitis was significantly more intense in eyes of
72            Using a mouse model of autoimmune uveoretinitis we examined monocyte trafficking to the in
73 ll clone that induce experimental autoimmune uveoretinitis when transferred into naive B10.A mice.